| Full Name | Shana Metzger |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | Psc 482, Fpo, Armed Forces Pacific |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336531854 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163W00000X | Registered Nurse | R201069 (Maryland) | Secondary |
| 363L00000X | Nurse Practitioner | R201069 (Maryland) | Primary |
| Entity Name | University Of Maryland Emergency Medicine Associates Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1144271743 PECOS PAC ID: 1951294941 Enrollment ID: O20040204000360 |
News Archive
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the presentation of clinical and non-clinical data on its lead product candidate, CRLX101, at the 2011 AACR-NCI-EORTC International Conference taking place from November 12-16 in San Francisco, California.
DelMar Pharmaceuticals, Inc. announced the presentation of interim clinical data from the company's ongoing clinical trial with VAL-083 in refractory glioblastoma multiforme (GBM) during the Central Nervous System Tumor Session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held at the McCormick Place Convention Center in Chicago.
The excess risk of death from ischemic (due to reduced blood flow), but not hemorrhagic (due to bleeding), stroke in US black children has decreased over the past decade, according to a study by Laura L. Lehman, M.D., of Boston Children's Hospital, and colleagues.
In an effort to educate and inform consumers, Water Pik, Inc., a global leader in personal healthcare products, today announced the launch of its new online community on Waterpik.com. Powered by Lithium Technologies, the online destination supports Water Pik's entire portfolio of oral health, shower head and sinus health products and brings the company's experts, consumers and industry experts together in one digital space.
› Verified 5 days ago
| Entity Name | Doctors Emergency Service, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528171840 PECOS PAC ID: 4486644598 Enrollment ID: O20040512001075 |
News Archive
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the presentation of clinical and non-clinical data on its lead product candidate, CRLX101, at the 2011 AACR-NCI-EORTC International Conference taking place from November 12-16 in San Francisco, California.
DelMar Pharmaceuticals, Inc. announced the presentation of interim clinical data from the company's ongoing clinical trial with VAL-083 in refractory glioblastoma multiforme (GBM) during the Central Nervous System Tumor Session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held at the McCormick Place Convention Center in Chicago.
The excess risk of death from ischemic (due to reduced blood flow), but not hemorrhagic (due to bleeding), stroke in US black children has decreased over the past decade, according to a study by Laura L. Lehman, M.D., of Boston Children's Hospital, and colleagues.
In an effort to educate and inform consumers, Water Pik, Inc., a global leader in personal healthcare products, today announced the launch of its new online community on Waterpik.com. Powered by Lithium Technologies, the online destination supports Water Pik's entire portfolio of oral health, shower head and sinus health products and brings the company's experts, consumers and industry experts together in one digital space.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Shana Metzger, Psc 567 Box 7070, Fpo, AP 96384-0071 Ph: () - | Shana Metzger, Psc 482, Fpo, AP 96362 Ph: (315) 646-7698 |
News Archive
The investigational anti- cancer drug, phenoxodiol, considerably enhances the ability of the drug, docetaxel (Taxotere(R), Sanofi-Aventis), to kill human ovarian cancer cells in the laboratory. The findings are reported in the current issue of Oncology Research.
Cerulean Pharma Inc., a leader in designing and developing tumor-targeted nanopharmaceuticals, today announced the presentation of clinical and non-clinical data on its lead product candidate, CRLX101, at the 2011 AACR-NCI-EORTC International Conference taking place from November 12-16 in San Francisco, California.
DelMar Pharmaceuticals, Inc. announced the presentation of interim clinical data from the company's ongoing clinical trial with VAL-083 in refractory glioblastoma multiforme (GBM) during the Central Nervous System Tumor Session at the 50th Annual Meeting of the American Society of Clinical Oncology (ASCO), which is being held at the McCormick Place Convention Center in Chicago.
The excess risk of death from ischemic (due to reduced blood flow), but not hemorrhagic (due to bleeding), stroke in US black children has decreased over the past decade, according to a study by Laura L. Lehman, M.D., of Boston Children's Hospital, and colleagues.
In an effort to educate and inform consumers, Water Pik, Inc., a global leader in personal healthcare products, today announced the launch of its new online community on Waterpik.com. Powered by Lithium Technologies, the online destination supports Water Pik's entire portfolio of oral health, shower head and sinus health products and brings the company's experts, consumers and industry experts together in one digital space.
› Verified 5 days ago
Kevin William Haws, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 475 Box 1442, Fpo, AP 96350 Phone: 011-819-035006263 | |
Evelyn Jean Tyler, NP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Box 254, Fpo, AP 96362 Phone: 011-816-11743 | |
Connie Jo Braybrook, PMHNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 482 Box 105, Fpo, AP 96362 Phone: 080-444-15338 | |
Dejanet Bailey, FNP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: U.s. Naval Hospital Okinawa, Psc 482, Fpo, AP 96362 Phone: 098-971-2202 | |
Tanya Beal Sinclair, N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Fpo, AP 96362 Phone: 315-643-7550 | |
Mrs. Salee Jane Oboza, NURSE PRACTITIONER Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: Psc 482, Box 2560, Fpo, AP 96362 Phone: 011-816-17437590 | |
Mrs. Meedeessa O Morgan, FNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Naval Hospital Yokosuka Japan, Fpo, AP 96530 Phone: 810-465-1666 |